Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Gout
A pilot clinical trial investigating the role of gut flora in gout has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2018-04-02Clinical Trial Update: Apremilast Therapy for Acute Gouty Arthritis [Phase 2]
A Phase 2 trial evaluating apremilast for acute gouty arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-11Clinical Trial Update: Allopurinol in Acute Gout [NA]
A clinical trial evaluating allopurinol for acute gout has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease [Phase 3]
A Phase 3 trial evaluating canakinumab for acute gouty arthritis in patients with chronic kidney disease has been withdrawn.
-
EMA withdrawal · 2016-07-22EMA Withdrawn: Krystexxa (pegloticase) — Crealta Pharmaceuticals Ireland Limited
EMA withdrew Krystexxa (pegloticase) from the market for gout.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.